Nicholas Investment Partners’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-189,392
| Closed | -$10.4M | – | 193 |
|
2020
Q3 | $10.4M | Buy |
189,392
+152,293
| +411% | +$8.4M | 1.13% | 31 |
|
2020
Q2 | $2.34M | Sell |
37,099
-39,497
| -52% | -$2.49M | 0.48% | 77 |
|
2020
Q1 | $3.91M | Buy |
76,596
+9,281
| +14% | +$474K | 0.76% | 44 |
|
2019
Q4 | $5.35M | Sell |
67,315
-27,048
| -29% | -$2.15M | 0.55% | 50 |
|
2019
Q3 | $4.58M | Buy |
94,363
+5,885
| +7% | +$286K | 0.39% | 96 |
|
2019
Q2 | $4.65M | Buy |
88,478
+19,090
| +28% | +$1M | 0.43% | 80 |
|
2019
Q1 | $3.67M | Buy |
69,388
+59,581
| +608% | +$3.15M | 0.33% | 103 |
|
2018
Q4 | $403K | Sell |
9,807
-95,316
| -91% | -$3.92M | 0.04% | 209 |
|
2018
Q3 | $4M | Sell |
105,123
-1,149
| -1% | -$43.7K | 0.32% | 121 |
|
2018
Q2 | $4.8M | Buy |
106,272
+58,994
| +125% | +$2.67M | 0.34% | 91 |
|
2018
Q1 | $2.28M | Sell |
47,278
-6,895
| -13% | -$333K | 0.16% | 179 |
|
2017
Q4 | $2.13M | Buy |
+54,173
| New | +$2.13M | 0.14% | 203 |
|
2017
Q2 | – | Sell |
-23,142
| Closed | -$852K | – | 285 |
|
2017
Q1 | $852K | Buy |
+23,142
| New | +$852K | 0.06% | 243 |
|